AstraZeneca PLC (AZN) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 5 113 | 9 085 | 13 422 | 15 438 | 19 829 | 20 467 | ||
| Changes by years, y/y, % | -37% | +78% | +48% | +15% | +28% | +19.7% | |||
AstraZeneca PLC. EBITDA US GAAP, bln rub
AstraZeneca PLC. EBITDA US GAAP, changes, %
AstraZeneca PLC. EBITDA US GAAP, sum by quarters, bln rub
AstraZeneca PLC (AZN) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 5 035 | 4 955 | 5 227 | 4 612 | 5 673 | 20 467 | |
| Changes by years, y/y, % | +13% | +20% | +27% | +64% | +13% | |||
| Changes by quarters, q/q, % | +79% | -2% | +5% | -12% | +23% | |||